|
MICB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.28250000000596E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.173300E-04 |
| Normal-vs-Stage2 |
5.303500E-03 |
| Normal-vs-Stage3 |
2.742100E-03 |
| Normal-vs-Stage4 |
2.767600E-01 |
| Stage1-vs-Stage2 |
7.766300E-02 |
| Stage1-vs-Stage3 |
6.539900E-02 |
| Stage1-vs-Stage4 |
8.629000E-01 |
| Stage2-vs-Stage3 |
7.185200E-01 |
| Stage2-vs-Stage4 |
2.520800E-01 |
| Stage3-vs-Stage4 |
2.203800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.167000E-04 |
| Normal-vs-AfricanAmerican |
3.166200E-04 |
| Normal-vs-Asian |
3.969200E-01 |
| Caucasian-vs-AfricanAmerican |
2.271400E-01 |
| Caucasian-vs-Asian |
7.446600E-01 |
| AfricanAmerican-vs-Asian |
9.033000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.44099999999092E-06 |
| Normal-vs-Female |
1.118020E-02 |
| Male-vs-Female |
3.979000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.837000E-01 |
| Normal-vs-Extreme_Weight |
1.52004999999233E-05 |
| Normal-vs-Obese |
5.156900E-03 |
| Normal-vs-Extreme_Obese |
6.556000E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.547710E-02 |
| Normal_Weight-vs-Obese |
1.645600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.140800E-01 |
| Extreme_Weight-vs-Obese |
3.640000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.959800E-02 |
| Obese-vs-Extreme_Obese |
2.604400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.073770E-01 |
| Normal-vs-Age(41-60Yrs) |
4.36520000002272E-06 |
| Normal-vs-Age(61-80Yrs) |
1.344890E-03 |
| Normal-vs-Age(81-100Yrs) |
1.302350E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.161000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.917600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.828400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.043200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.733400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.048400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.026000E-04 |
| Normal-VS-Type2 PRCC |
7.779400E-04 |
| Normal-VS-KIRP CIMP |
6.971400E-01 |
| Normal-VS-Unclassified PRCC |
1.024570E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.852390E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.957000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.411860E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.753800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.311800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.157900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.858700E-03 |
| Normal-vs-N1 |
7.082300E-03 |
| Normal-vs-N2 |
4.868600E-01 |
| N0-vs-N1 |
2.782000E-01 |
| N0-vs-N2 |
8.467000E-01 |
| N1-vs-N2 |
5.424800E-01 |
|
|
